{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:00:27Z","timestamp":1790420427231,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007380.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000}}],"reference-count":152,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007380.pub4","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T11:35:23Z","timestamp":1474976123000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Psychostimulant drugs for cocaine dependence"],"prefix":"10.1002","volume":"2016","author":[{"given":"Xavier","family":"Castells","sequence":"first","affiliation":[{"name":"Universitat de Girona; Unit of Clinical Pharmacology, TransLab Research Group, Department of Medical Sciences; Emili Grahit, 77 Girona Catalonia Spain 17071"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Cunill","sequence":"additional","affiliation":[{"name":"Parc Sanitari Sant Joan de D\u00e9u; Parc Sanitari Sant Joan de D\u00e9u-Numancia; Barcelona Catalunya Spain 08735"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"P\u00e9rez-Ma\u00f1\u00e1","sequence":"additional","affiliation":[{"name":"Universitat Aut\u00f2noma de Barcelona; Integrative Pharmacology and Systems Neuroscience Research Group, Hospital del Mar Research Institute-IMIM, Parc de Salut Mar, and Department of Pharmacology, Therapeutics and Toxicology; Doctor Aiguader 88 Barcelona Catalonia Spain 08003"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Vidal","sequence":"additional","affiliation":[{"name":"Hospital Universitari Vall d'Hebron, Universitat Aut\u00f2noma de Barcelona; Department of Clinical Pharmacology; Passeig Vall d'Hebron 119-129 Barcelona Catalonia Spain 08035"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Capell\u00e0","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitat de Girona; Unit of Clinical Pharmacology, TransLab Research Group, Department of Medical Sciences; Girona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,9,27]]},"reference":[{"issue":"1-2","key":"10.1002\/14651858.CD007380.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.npp.1300600","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"30","author":"Dackis","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0003|cit3","first-page":"www.cpdd.org\/Pa","article-title":"Factors involved in predicting the success of modafinil for the treatment of cocaine-dependent subjects","author":"Starosta","journal-title":"68th Annual Scientific Meeting of the College on Problems of Drug Dependence"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0005|cit5","first-page":"104","article-title":"A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription","volume":"33","author":"D\u00fcrsteler-MacFarland","year":"2013","journal-title":"Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2006.04.010","article-title":"Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence","volume":"85","author":"Elkashef","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0007|cit7","first-page":"436","article-title":"Methylphenidate (MP) for initial treatment of cocaine dependence and a model for medication evaluation","volume":"141","author":"Grabowki","year":"1994","journal-title":"NIDA Research Monograph"},{"issue":"6","key":"10.1002\/14651858.CD007380.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004714-199712000-00008","article-title":"Replacement medication for cocaine dependence: methylphenidate","volume":"17","author":"Grabowski","year":"1997","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD007380.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment:a double-blind randomised clinical trial","volume":"21","author":"Grabowski","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD007380.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","article-title":"Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials","volume":"29","author":"Grabowski","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"Oct","key":"10.1002\/14651858.CD007380.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2015.08.005","article-title":"A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence","volume":"155","author":"Kampman","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD007380.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/00952990600919005","article-title":"Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence effects on outcome","volume":"32","author":"Aharonovich","year":"2006","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drugalcdep.2006.07.004","article-title":"Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo","volume":"87","author":"Levin","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1002\/14651858.CD007380.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","article-title":"Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder: a randomized clinical trial","volume":"72","author":"Levin","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0376-8716(95)01198-6","article-title":"A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients","volume":"40","author":"Margolin","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD007380.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/00952999509002711","article-title":"Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients","volume":"21","author":"Margolin","year":"1995","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/08897079709511358","article-title":"High- and low-dose mazindol for cocaine dependence in methadone-maintained patients:a preliminary evaluation","volume":"18","author":"Margolin","year":"1997","journal-title":"Substance Abuse"},{"issue":"1-2","key":"10.1002\/14651858.CD007380.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","article-title":"Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial","volume":"101","author":"Mooney","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"Aug","key":"10.1002\/14651858.CD007380.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2015.05.042","article-title":"Pilot study of the effects of lisdexamfetamine on cocaine use: a randomized, double-blind, placebo-controlled trial","volume":"153","author":"Mooney","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"Mar","key":"10.1002\/14651858.CD007380.pub4-BIB0020|cit20","first-page":"49","article-title":"Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence","volume":"160","author":"Morgan","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0021|cit21","unstructured":"NCT00142818 Modafinil and naltrexone to reduce cocaine and alcohol dependence (Mod-Nal) clinicaltrials.gov\/show\/NCT00142818"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1300\/J374v01n01_04","article-title":"Mazindol augmentation of antipsychotic treatment for schizophrenic patients with comorbid cocaine abuse or dependence: a preliminary double-blind, randomized, placebo-controlled trial","volume":"1","author":"Perry","year":"2004","journal-title":"Journal of Dual Diagnosis"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archpsyc.63.2.219","article-title":"Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population","volume":"63","author":"Poling","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"Aug","key":"10.1002\/14651858.CD007380.pub4-BIB0024|cit24","first-page":"77","article-title":"Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: a preliminary investigation","volume":"3","author":"Schmitz","year":"2012","journal-title":"Frontiers in Psychiatry\/Frontiers Research Foundation"},{"issue":"Mar","key":"10.1002\/14651858.CD007380.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2013.12.015","article-title":"A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa,naltrexone","volume":"136","author":"Schmitz","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0026|cit26","first-page":"116","article-title":"Double-blind placebo controlled stimulant trial for cocaine dependent ADHD adults","volume":"180","author":"Downey","year":"2000","journal-title":"NIDA Research Monograph"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1037\/1064-1297.10.3.286","article-title":"Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence","volume":"10","author":"Schubiner","year":"2002","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD007380.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1360-0443.2003.00447.x","article-title":"Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence","volume":"98","author":"Shearer","year":"2003","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1300\/J069v27n01_02","article-title":"Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse\/dependence","volume":"27","author":"Shoptaw","year":"2008","journal-title":"Journal of Addictive Diseases"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0376-8716(95)01174-4","article-title":"Mazindol treatment for cocaine dependence","volume":"39","author":"Stine","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/00952990.2011.644002","article-title":"The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression","volume":"38","author":"Afshar","year":"2012","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0740-5472(97)00226-2","article-title":"A comprehensive pharmacologic-psychosocial treatment program for HIV-seropositive cocaine-and-opioid-dependent patients. Preliminary findings","volume":"15","author":"Avants","year":"1998","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"8632","key":"10.1002\/14651858.CD007380.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(89)91299-3","article-title":"Treatment of cocaine abuse with mazindol","volume":"1","author":"Berger","year":"1989","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD007380.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.addbeh.2014.02.015","article-title":"Preliminary evidence for normalization of risk taking by modafinil in chronic cocaine users","volume":"39","author":"Canavan","year":"2014","journal-title":"Addict Behaviors"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0269881108096982","article-title":"Liking and wanting of drug and non-drug rewards in active cocaine users: the STRAP-R questionnaire","volume":"24","author":"Goldstein","year":"2010","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/npp.2010.145","article-title":"Oral methylphenidate normalizes cingulate activity and decreases impulsivity in cocaine addiction during an emotionally salient cognitive task","volume":"36","author":"Goldstein","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"Supplement","key":"10.1002\/14651858.CD007380.pub4-BIB0037|cit37","first-page":"S21","article-title":"Agonist-like medications for cocaine dependence treatment: clinical studies","volume":"35","author":"Herin","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"Supplement","key":"10.1002\/14651858.CD007380.pub4-BIB0038|cit38","first-page":"S176","article-title":"Short-term modafinil administration improves working memory and sustained attention in cocaine-dependent volunteers","volume":"36","author":"Kalechstein","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"Jan","key":"10.1002\/14651858.CD007380.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.neuropharm.2012.06.064","article-title":"Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users","volume":"64","author":"Kalechstein","year":"2013","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1002\/14651858.CD007380.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0740-5472(97)00018-4","article-title":"Combination of the dopaminergic agent, phentermine, and the serotoninergic agent, fenfluramine, in the treatment of cocaine dependence","volume":"14","author":"Kampman","year":"1997","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1002\/14651858.CD007380.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4088\/JCP.v59n0605","article-title":"Methylphenidate treatment for cocaine abusers with adult attention-deficit\/hyperactivity disorder: a pilot study","volume":"59","author":"Levin","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0042|cit42","first-page":"39","article-title":"Methylphenidate treatment for cocaine abusers with adult attention-deficit\/hyperactivity disorder","volume":"179","author":"Levin","year":"1999","journal-title":"NIDA Research Monograph"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.drugalcdep.2005.06.012","article-title":"Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo","volume":"81","author":"Levin","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jsat.2006.11.012","article-title":"Effects of major depressive disorder and attention-deficit\/hyperactivity disorder on the outcome of treatment for cocaine dependence","volume":"34","author":"Levin","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1002\/14651858.CD007380.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/ntr\/ntv121","article-title":"Evaluating nicotine craving, withdrawal, and substance use as mediators of smoking cessation in cocaine- and methamphetamine-dependent patients","volume":"18","author":"Magee","year":"2015","journal-title":"Nicotine & Tobacco Research"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1037\/ccp0000054","article-title":"The coupling of nicotine and stimulant craving during treatment for stimulant dependence","volume":"84","author":"Magee","year":"2016","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archpsyc.1991.01810250089015","article-title":"Bupropion reduces cocaine abuse in methadone-maintained patients","volume":"48","author":"Margolin","year":"1991","journal-title":"Archives of Geneneral Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007380.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.biopsych.2012.05.032","article-title":"Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial","volume":"72","author":"Mariani","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"Supplement","key":"10.1002\/14651858.CD007380.pub4-BIB0049|cit49","first-page":"S285","article-title":"Pharmacological MRI of d-amphetamine: effects of a go-no\/go task in cocaine dependent subjects","volume":"36","author":"Moeller","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/cercor\/bhs345","article-title":"Methylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addiction","volume":"24","author":"Moeller","year":"2014","journal-title":"Cerebral Cortex"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0051|cit51","first-page":"304","article-title":"Safety and efficacy of bupropion in combination with bromocriptine for treatment of cocaine dependence","volume":"153","author":"Montoya","year":"1994","journal-title":"NIDA Research Monograph"},{"issue":"4","key":"10.1002\/14651858.CD007380.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/10550490802138814","article-title":"Preliminary study of buprenorphine and bupropion for opioid dependent smokers","volume":"17","author":"Mooney","year":"2008","journal-title":"American Journal on Addictions"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1176\/appi.ajp.2009.09050613","article-title":"Normalizing effects of modafinil on sleep in chronic cocaine users","volume":"167","author":"Morgan","year":"2010","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007380.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0269881115582151","article-title":"Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial","volume":"29","author":"Nuijten","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00002826-199619010-00003","article-title":"Lack of neurotoxic effect of diethylpropion in crack-cocaine abusers","volume":"19","author":"Ollo","year":"1996","journal-title":"Clinical Neuropharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/00952990802455444","article-title":"Correlates of stimulant treatment outcome across treatment modalities","volume":"35","author":"Peirce","year":"2009","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"5","key":"10.1002\/14651858.CD007380.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1521-0391.2010.00066.x","article-title":"The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study","volume":"19","author":"Poling","year":"2010","journal-title":"The American Journal on Addictions"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/JCP.0b013e3181d21967","article-title":"Cocaine choice in humans during D-amphetamine maintenance","volume":"30","author":"Rush","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD007380.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0006-3223(92)90171-U","article-title":"Mazindol and cocaine addiction in schizophrenia","volume":"31","author":"Seibyl","year":"1992","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1465-3362.2009.00148.x","article-title":"A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence","volume":"39","author":"Shearer","year":"2010","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2012.11.021","article-title":"The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: a pilot study","volume":"131","author":"Shorter","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0062|cit62","first-page":"512","article-title":"Clinical trial of multiple treatment agents for cocaine dependence: a placebo-controlled elimination study","volume":"105","author":"Tennant","year":"1990","journal-title":"NIDA Research Monograph"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/00952990802013565","article-title":"Effects of potential agonist-replacement therapies for stimulant dependence on inhibitory control in cocaine abusers","volume":"34","author":"Vansickel","year":"2008","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"Supplement","key":"10.1002\/14651858.CD007380.pub4-BIB0064|cit64","first-page":"S39","article-title":"Decreased motivation in ADHD is associated with deficit in dopamine reward pathway","volume":"35","author":"Volkow","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2009.09.002","article-title":"Modafinil does not serve as a reinforcer in cocaine abusers","volume":"15","author":"Vosburg","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"Supplement","key":"10.1002\/14651858.CD007380.pub4-BIB0066|cit66","first-page":"S372","article-title":"Decreased striatal and prefrontal dopaminergic responses in active cocaine dependent subjects","volume":"35","author":"Wang","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD007380.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jsat.2012.12.005","article-title":"Impulsivity is associated with treatment non-completion in cocaine- and methamphetamine-dependent patients but differs in nature as a function of stimulant-dependence diagnosis","volume":"44","author":"Winhusen","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1002\/14651858.CD007380.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4088\/JCP.13m08449","article-title":"A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers","volume":"75","author":"Winhusen","year":"2014","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0069|cit69","unstructured":"EudraCT 2013-004024-11 New pharmacotherapeutic treatment options for crack-cocaine dependent people in the Netherlands: A double-blind, placebo-controlled randomized feasibility study of sustained release dexamphetamine www.clinicaltrialsregister.eu\/ctr-search\/search?query=2013-004024-11"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0070|cit70","unstructured":"NCT00015223 Methylphenidate in the treatment of cocaine dependent patients with adult attention deficit hyperactivity disorder clinicaltrials.gov\/show\/NCT00015223"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0071|cit71","unstructured":"NCT00218348 Treatment of cocaine dependence: comparison of three doses of dextro-amphetamine sulfate and placebo clinicaltrials.gov\/show\/NCT00218348"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0072|cit72","unstructured":"NCT00218387 Modafinil combined with cognitive behavior therapy to treat cocaine addiction clinicaltrials.gov\/show\/study\/NCT00218387"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0073|cit73","unstructured":"NCT00344565 A placebo-controlled double-blind combined treatment of modafinil and CBT for cocaine dependence clinicaltrials.gov\/show\/NCT00344565"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0074|cit74","unstructured":"NCT00495092 Efficacy of caffeine, with and without biperiden, in the detoxification of cocaine dependent patients clinicaltrials.gov\/show\/NCT00495092"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0075|cit75","unstructured":"NCT00514202 Pilot study examining effect for dextroamphetamine to treat cocaine dependence plus attention-deficit hyperactivity disorder (ADHD) clinicaltrials.gov\/ct2\/show\/NCT00514202"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0076|cit76","unstructured":"NCT00701532 Brain imaging study of the effects of modafinil in cocaine addiction clinicaltrials.gov\/ct2\/show\/NCT00701532"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0077|cit77","unstructured":"NCT00733993 Caffeine and cocaine clinicaltrials.gov\/show\/NCT00733993"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0078|cit78","unstructured":"NCT00838981 Pharmacotherapy and CM for opioid and cocaine dependence clinicaltrials.gov\/show\/NCT00838981"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0079|cit79","unstructured":"NCT00218036 Pharmacotherapy dosing regimen in cocaine and opiate dependent individuals - 8 clinicaltrials.gov\/show\/NCT00218036"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0080|cit80","unstructured":"NCT02111798 Bupropion-enhanced contingency management for cocaine dependence clinicaltrials.gov\/ct2\/show\/NCT02111798"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0081|cit81","unstructured":"NTC00123383 Randomized placebo-controlled trial of modafinil for cocaine dependence clinicaltrials.gov\/ct2\/show\/NTC00123383"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0082|cit82","volume-title":"AHFS. American Hospital Formulary Service. Drug Information 2009","author":"American Society of Health-System Pharmacists","year":"2014"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0083|cit83","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (4th ed.)","author":"American Psychiatry Association","year":"2000"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0084|cit84","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (5th ed.)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0085|cit85","unstructured":"World Health Organization ATC\/DDD Index www.whocc.no\/atcddd\/indexdatabase\/"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0086|cit86","volume-title":"Martindale: The Complete Drug Reference","author":"Brayfield","year":"2014"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0087|cit87","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2011"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archpsyc.61.3.264","article-title":"Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial","volume":"61","author":"Carroll","year":"2004","journal-title":"Archives of General Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD007380.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1360-0443.2007.01943.x","article-title":"Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomised controlled clinical trials","volume":"1002","author":"Castells","year":"2007","journal-title":"Addiction"},{"issue":"5","key":"10.1002\/14651858.CD007380.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/00952990903108215","article-title":"Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: a systematic review and meta-analysis of controlled clinical trials","volume":"35","author":"Castells","year":"2009","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"4","key":"10.1002\/14651858.CD007380.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1521-0391.2013.12032.x","article-title":"Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users","volume":"22","author":"Cunningham","year":"2013","journal-title":"American Journal of Addictions"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s002130100802","article-title":"Acute doses of d-amphetamine and bupropion increase cigarette smoking","volume":"157","author":"Cousins","year":"2001","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0376-8716(96)01259-8","article-title":"Discriminative stimulus effects of cocaine in female versus male rats","volume":"42","author":"Craft","year":"1996","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0269881114544777","article-title":"Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence","volume":"29","author":"Cunill","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"1-3","key":"10.1002\/14651858.CD007380.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2007.03.044","article-title":"Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants","volume":"568","author":"Dopheide","year":"2007","journal-title":"European Journal of Pharmacology"},{"issue":"3-4","key":"10.1002\/14651858.CD007380.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1527-3458.2006.00178.x","article-title":"Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent","volume":"12","author":"Dwoskin","year":"2006","journal-title":"CNS Drug Reviews"},{"issue":"7109","key":"10.1002\/14651858.CD007380.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0098|cit98","unstructured":"European Monitoring Centre for Drugs and Drug Addiction European Drug Report. Trends and developments www.emcdda.europa.eu\/attachements.cfm\/att_239505_EN_TDAT15001ENN.pdf"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0099|cit99","first-page":"841","article-title":"Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons","volume":"259","author":"Engberg","year":"1991","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0100|cit100","first-page":"817","article-title":"Amphetamine-like effects of anorectics and related compounds in pigeons","volume":"241","author":"Evans","year":"1987","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"14","key":"10.1002\/14651858.CD007380.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2165\/00003495-200464140-00004","article-title":"Agents in development for the management of cocaine abuse","volume":"64","author":"Gorelick","year":"2004","journal-title":"Drugs"},{"issue":"7","key":"10.1002\/14651858.CD007380.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.addbeh.2004.06.018","article-title":"Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence","volume":"29","author":"Grabowski","year":"2004","journal-title":"Addictive Behaviors"},{"issue":"7454","key":"10.1002\/14651858.CD007380.pub4-BIB0103|cit103","first-page":"149","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"The GRADE Working Group","year":"2004","journal-title":"BMJ"},{"issue":"7650","key":"10.1002\/14651858.CD007380.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD007380.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD007380.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/add.12633","article-title":"Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews","volume":"109","author":"Hartmann-Boyce","year":"2014","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0107|cit107","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00002826-200005000-00004","article-title":"Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy","volume":"23","author":"Jasinski","year":"2000","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/9780470693926.ch5","article-title":"Assessing the quality of clinical trials","volume-title":"Systematic Reviews in Health Care. Meta Analysis in Context","author":"J\u00fcni","year":"2001"},{"issue":"8","key":"10.1002\/14651858.CD007380.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10550490601184142","article-title":"Neurobiology of cocaine addiction: implications for new pharmacotherapy","volume":"16","author":"Kalivas","year":"2007","journal-title":"American Journal on Addictions"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/S1461145707008097","article-title":"New treatments for cocaine dependence: a focused review","volume":"11","author":"Karila","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s002130050029","article-title":"Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects","volume":"148","author":"Katz","year":"2000","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.drugalcdep.2003.11.014","article-title":"Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program","volume":"74","author":"Kidorf","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD007380.pub4-BIB0116|cit116","first-page":"5","article-title":"Treatment of patients with substance use disorders, second edition","volume":"164","author":"Kleber","year":"2007","journal-title":"American Journal of Psychiatry"},{"issue":"4879","key":"10.1002\/14651858.CD007380.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1126\/science.2903550","article-title":"Cellular and molecular mechanisms of drug dependence","volume":"242","author":"Koob","year":"1988","journal-title":"Science"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550490590899817","article-title":"Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response","volume":"14","author":"Kosten","year":"2005","journal-title":"American Journal on Addictions"},{"issue":"6","key":"10.1002\/14651858.CD007380.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/JCP.0b013e3181c09475","article-title":"Abuse potential of bupropion nasal insufflation: a case report","volume":"29","author":"Langguth","year":"2009","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD007380.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0006-3223(02)01834-6","article-title":"In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography","volume":"54","author":"Learned-Coughlin","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","article-title":"Understanding polydrug use: review of heroin and cocaine co-use","volume":"98","author":"Leri","year":"2003","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.106.106583","article-title":"Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro","volume":"319","author":"Madras","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00003088-199733020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of selegiline. An update","volume":"33","author":"Mahmood","year":"1997","journal-title":"Clinical Pharmacokinetics"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1037\/1064-1297.15.2.123","article-title":"Behavioral andsubjective effects of d-amphetamine and modafinil in healthy adults","volume":"15","author":"Makris","year":"2007","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"CD002209","key":"10.1002\/14651858.CD007380.pub4-BIB0126|cit126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.0306-5251.2001.01538.x","article-title":"Recreational bupropion abuse in a teenager","volume":"53","author":"McCormick","year":"2002","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drugalcdep.2005.03.026","article-title":"Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial","volume":"80","author":"McDowell","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1002\/14651858.CD007380.pub4-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003352.pub4","article-title":"Dopamine agonists for the treatment of cocaine dependence","author":"Minozzi","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007380.pub4-BIB0130|cit130","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006754.pub4","article-title":"Anticonvulsants for cocaine dependence","author":"Minozzi","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD007380.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11920-008-0062-x","article-title":"Use of stimulants to treat cocaine and methamphetamine abuse","volume":"10","author":"Moeller","year":"2008","journal-title":"Current Psychiatry Reports"},{"issue":"12","key":"10.1002\/14651858.CD007380.pub4-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002950.pub3","article-title":"Antidepressants for cocaine dependence and problematic cocaine use","author":"Pani","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bcp.12045","article-title":"Pharmacological \u2029and \u2029clinical \u2029dilemmas\u2029 of\u2029 prescribing \u2029in \u2029comorbid \u2029adult \u2029attention deficit\/hyperactivity \u2029disorder \u2029and addiction","volume":"77","author":"P\u00e9rez\u2029 de \u2029los \u2029Cobos","year":"2014","journal-title":"British \u2029Journal\u2029 of\u2029 Clinical\u2029 Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00008877-200502000-00007","article-title":"Effects of acute bupropion administration on locomotor activity in adolescent and adult mice","volume":"16","author":"Redolat","year":"2005","journal-title":"Behavioral Pharmacology"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0135|cit135","unstructured":"Substance Abuse and Mental Health Services Administration (SAMSHA) Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014 Available from: www.samhsa.gov\/data\/sites\/default\/files\/NSDUHresultsPDFWHTML2013\/Web\/NSDUHresults2013.pdf"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2007.11.004","article-title":"Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform","volume":"94","author":"Schmitz","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1478-4505-4-26","article-title":"Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation","volume":"4","author":"Schunemann","year":"2006","journal-title":"Health Research Policy & Systems"},{"issue":"6","key":"10.1002\/14651858.CD007380.pub4-BIB0138|cit138","first-page":"657","article-title":"Metabolism of selegiline in humans. Identification, excretion, and stereochemistry of urine metabolites","volume":"25","author":"Shin","year":"1997","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0139|cit139","unstructured":"United Nations Office on Drug and Crime World Drug Report www.unodc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf"},{"issue":"1-2","key":"10.1002\/14651858.CD007380.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugalcdep.2011.12.007","article-title":"Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis","volume":"122","author":"Emmerik-Van Oortmerssen","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1002\/14651858.CD007380.pub4-BIB0141|cit141","first-page":"719","article-title":"Effects of chronic cocaine abuse on postsynaptic dopamine receptors","volume":"147","author":"Volkow","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007380.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0893-133X(95)00073-M","article-title":"Cocaine uptake is decreased in the brain of detoxified cocaine abusers","volume":"14","author":"Volkow","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"6627","key":"10.1002\/14651858.CD007380.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/386827a0","article-title":"Relationship between subjective effects of cocaine and dopamine transporter occupancy","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"issue":"6627","key":"10.1002\/14651858.CD007380.pub4-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/386830a0","article-title":"Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1002\/14651858.CD007380.pub4-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.mp.4001507","article-title":"Dopamine in drug abuse and addiction: results from imaging studies and treatment implications","volume":"9","author":"Volkow","year":"2004","journal-title":"Molecular Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007380.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD007380.pub4-BIB0147|cit147","unstructured":"World Anti-Doping Agency List of Prohibited Substances and Methods (available from: http:\/\/list.wada-ama.org\/) Internet resource 2016"},{"issue":"12","key":"10.1002\/14651858.CD007380.pub4-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJM200209193471222","article-title":"Seizure induced by insufflation of bupropion","volume":"347","author":"Welsh","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007380.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/jpet.105.096263","article-title":"Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl]","volume":"317","author":"Yasar","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD007380.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00213-005-0200-7","article-title":"A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys","volume":"183","author":"Yasar","year":"2006","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007380.pub4-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.108.146142","article-title":"Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil","volume":"329","author":"Zolkowska","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"CD007380","key":"10.1002\/14651858.CD007380.pub4-BIB0152|cit152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007380.pub3","article-title":"Efficacy of psychostimulant drugs for cocaine dependence","author":"Castells","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007380.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T09:53:32Z","timestamp":1695030812000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007380.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,27]]},"references-count":152,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007380.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,27]]}}}